|
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
|
|
|
|
zd1839治疗晚期非小细胞肺癌的临床观察
, PP. 1061-1063
Keywords: zd1839/副作用,非小细胞肺癌/化学治疗,疾病控制率,表皮生长因子受体
Abstract:
目的观察zd1839治疗晚期非小细胞肺癌的疗效和毒副作用。方法以一定的标准选取32例晚期非小细胞肺癌病人,口服zd1839治疗,90d后观察其疗效及毒副反应。结果完全缓解(cr)0%,部分缓解(pr)18.75%,稳定(sd)37.50%,疾病控制率(cr+pr+sd)56.25%。毒副作用中,出现痤疮样皮疹10例(31.25%),腹泻6例(18.75%),转氨酶升高4例(12.50%),恶心、呕吐5例(15.63%),未发现间质性肺炎病例。结论zd1839是一种新药,其疾病控制率和毒副作用对于肺癌患者来说是可以接受的,在治疗肺癌方面具有良好的前景。
| [1] | sirotnakfm.studieswithzd1839inpreclinicalmodels[j].seminoncol,2003,30(1suppl1):12-20.
|
| [2] | ritterca,arteagacl.theepidermalgrowthfactorreceptor-tyrosinekinase:apromisingtherapeutictargetinsolidtumors[j].seminoncol,2003,30(1suppl1):3-11.
|
| [3] | herbstrs.dose-comparativemonotherapytrialsofzd1839inpreviouslytreatednon-smallcelllungcancerpatients[j].seminoncol,2003,30(1suppl1):30-8.
|
| [4] | fukuokam,yanos,giacconeg,etal.multi-institutionalrandomizedphaseⅱtrialofgefitinibforpreviouslytreatedpatientswithadvancednon-small-celllungcancer[j].jclinoncol,2003,21(12):2237-46.
|
| [5] | schillerjh.newdirectionsforzd1839inthetreatmentofsolidtumors[j].seminoncol,2003,30(1suppl1):49-55.
|
| [6] | baselgaj,rischind,ransonm.phaseⅰsafety,pharmacokinetic,andpharmacodynamictrialofzd1839,aselectiveoralepidermalgrowthfactorreceptortyrosinekinaseinhibitor,inpatientswithfiveselectedsolidtumortypes[j].jclinoncol,2002,20(21):4292-302.
|
| [7] | lorussopm.phaseⅰstudiesofzd1839inpatientswithcommonsolidtumors[j].seminoncol,2003,30(suppl1):21-9.
|
| [8] | 李新旭,周同冲,赵健.非小细胞肺癌骨转移综合治疗临床分析[j].第一军医大学学报,2003,23(7):752-3.lixx,zhoutc,zhaoj.clinicalevaluationofcombined-modalitytherapyforbonemetastasisofnon-small-celllungcancer[j].jfirstmilmeduniv/diyijunyidaxuexuebao,2003,23(7):752-3.
|
| [9] | 蔡红兵,代方国,闵清芬,等.中医药配合放疗治疗非小细胞肺癌的临床研究[j].第一军医大学学报,2002,22(12):1112-3.caihb,daifg,minqf,etal.clinicalstudyoftheeffectsofradiotherapyincombinationwithtraditionalchinesemedicineonnonsmallcelllungcancer[j].jfirstmilmeduniv/diyijunyidaxuexuebao,2002,22(12):1112-3.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|
